Although I wrote this one last week, it took a little while to get up on the site. Enjoy.
As I look at the earnings report for pharmaceutical giant Bristol-Myers Squibb (NYSE: BMY), I wonder if the rally in the stock is more of an expression of relief than excitement. Like many of its big-cap pharma brethren, there has been more than just one wall of worry to climb for BMY.
For the rest, please go to: http://stocks.investopedia.
No comments:
Post a Comment